Curis Lifesciences P/E Ratio
Current P/E Ratio
16.62
Moderate Valuation
Moderate - Fairly valued
Curis Lifesciences (CURIS) P/E ratio is 16.62 (Moderate), EPS (TTM) ₹10.26, current price ₹ on None — Moderate - Fairly valued. Compare with CURIS fair price to assess whether the stock is under or overvalued.
Current Valuation Metrics
P/E Ratio
16.62
Current Price
₹
EPS (TTM)
₹10.26
Exchange
None
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
55.08
Sector Median
30.97
Sector Rank
#11 of 198
Sector Percentile
5.6%
Earnings Breakdown (TTM)
TTM EPS
₹24.00
Jun 2024
₹24.00
CURIS P/E Ratio — Valuation Signal & Historical Context
Curis Lifesciences P/E 16.62 — signal: Fairly Valued. For live price, revenue and the complete fundamental profile, see CURIS share price.
- Trading at discount to sector average PE of 55.08
CURIS vs Healthcare Peers — P/E Ratio Comparison
Curis Lifesciences P/E 16.62 vs Healthcare average 55.08, median 30.97 — range 2.86–706.0.
Sector Average
55.08
Sector Median
30.97
Lowest P/E
2.86
Highest P/E
706.0
Companies
198
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 2.98 | ₹52 | Low |
| Colinz Laboratories | COLINZ | 3.6 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.19 | ₹67 | Low |
| Shelter Pharma | SHELTER | 4.99 | ₹46 | Low |
| JFL Life Sciences | JFLLIFE | 5.83 | ₹78 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 6.73 | ₹48 | Low |